Unique particles modified to mimic bacteria may provide a better means of treating infectious diseases, such as tuberculosis. Assistant Professor Joshua Reineke of the South Dakota State University Department of Pharmaceutical Sciences and his team modified microparticles, known as metal organic frameworks (MOFs), developed by a research group in France. Other researchers have explored MOFs as a drug-delivery system to […]

Continue reading »